Caldeira, Daniel
Rodrigues, Bárbara Sucena
Alves, Mariana
Pinto, Fausto J.
Ferreira, Joaquim J.
Article History
Received: 21 December 2021
Accepted: 26 January 2022
First Online: 16 February 2022
Declarations
:
: Due to methodology of systematic review and meta-analysis, ethical approval and participants consent was not needed.
: All authors have seen and approved the final version of the manuscript.
: DC has participated in educational meetings and/or attended a conferences or symposia (including travel, accommodation) with Daiichi Sankyo, Menarini, Merck Serono and Roche, in the last 3 years. MA reported participation in conferences with Boehringer-Ingelheim, AstraZeneca, Bayer, Bristol-Myers-Squibb, Grünenthal, Tecnimede, Merck Sharp & Dohme. FJP had consultant and speaker fees with Astra Zeneca, Bayer, BMS, Boehringer Ingelheim and Daiichi Sankyo. JJF is a consultant for Ipsen, GlaxoSmithKline, Novartis, Teva, Lundbeck, Solvay, Abbott, BIAL, Merck-Serono, and Merz; received grants from GlaxoSmithKline, Grunenthal, Teva, and Fundação MSD.